Should I buy or sell CellaVision AB (publ) stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CellaVision AB (publ) in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLVSF shares. View CLVSF analyst ratings or view top-rated stocks .

How have CLVSF shares performed in 2024?

CellaVision AB (publ)'s stock was trading at $16.72 at the beginning of 2024. Since then, CLVSF stock has increased by 21.1% and is now trading at $20.24. View the best growth stocks for 2024 here .

Are investors shorting CellaVision AB (publ)?

CellaVision AB (publ) saw a decline in short interest in April. As of April 15th, there was short interest totaling 1,300 shares, a decline of 13.3% from the March 31st total of 1,500 shares. Based on an average daily volume of 200 shares, the short-interest ratio is presently 6.5 days. View CellaVision AB (publ)'s Short Interest .

How do I buy shares of CellaVision AB (publ)?

Shares of CLVSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CLVSF

CellaVision AB (publ) (CLVSF) Stock Price, News & Analysis

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)

Free CLVSF Stock Alerts

$20.24

-0.12 (-0.59%)

(As of 04/26/2024 ET)

Compare

Today's Range: $20.24
▼
$20.24
50-Day Range: $16.72
▼
$23.75
52-Week Range: $20.24
▼
$23.75

Volume: 500 shs
Average Volume: 533 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get CellaVision AB (publ) alerts:

Ad Banyan Hill Publishing

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

About CellaVision AB (publ) Stock (OTCMKTS:CLVSF)

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a web-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, the company offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.

CLVSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CLVSF Stock News Headlines

April 18, 2024 | americanbankingnews.com

CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Large Decline in Short Interest

See More Headlines

Receive CLVSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CellaVision AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:CLVSF
CUSIP: N/A
CIK: N/A
Web: www.cellavision.com
Phone: (646) 460-1600
Fax: N/A
Employees: 228
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Christer Fahraeus B.Sc. Maths (Age 59)
h.c., MSc Bio Eng, Ph.D., Founder & Director
Comp: $285k
Mr. Simon Ostergaard (Age 53)
CEO & President
Mr. Magnus Blixt (Age 58)
Chief Financial Officer

Key Competitors

View All Competitors

CLVSF Stock Analysis - Frequently Asked Questions

Should I buy or sell CellaVision AB (publ) stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CellaVision AB (publ) in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLVSF shares.
View CLVSF analyst ratings or view top-rated stocks.
How have CLVSF shares performed in 2024?: CellaVision AB (publ)'s stock was trading at $16.72 at the beginning of 2024. Since then, CLVSF stock has increased by 21.1% and is now trading at $20.24.
View the best growth stocks for 2024 here.
Are investors shorting CellaVision AB (publ)?: CellaVision AB (publ) saw a decline in short interest in April. As of April 15th, there was short interest totaling 1,300 shares, a decline of 13.3% from the March 31st total of 1,500 shares. Based on an average daily volume of 200 shares, the short-interest ratio is presently 6.5 days.
View CellaVision AB (publ)'s Short Interest.
How do I buy shares of CellaVision AB (publ)?: Shares of CLVSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLVSF) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial